(Total Views: 59)
Posted On: 10/20/2020 10:36:02 AM
Post# of 27361

$ALRN News Article - Aileron Therapeutics to Host Conference Call to Discuss Results from Phase 1b Proof-of-Concept Study of Chemoprotective Therapy ALRN-6924 Being Presented at EORTC-NCI-AACR Annual Symposium https://marketwirenews.com/news-releases/aile...36357.html


My Twitter: WhyteStocks